Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
- June - July - August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
- 2013 -
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
June 2013 - 48 products
L
IP
CI
CM
Rivastigmin Patch Sandoz 5
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 9 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
CM
Rivastigmin Patch Sandoz 10
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 18 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
CM
Rivastigmin Patch Sandoz 10
60
79.02
102.35
10 %
Transdermal patch: Rivastigminum 18 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Rivastigmin Patch Sandoz 15
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 27 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Rivastigmin Patch Sandoz 15
60
79.02
102.35
10 %
Transdermal patch: Rivastigminum 27 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 4
28 Tablet(s)
16.80
34.70
10 %
Chewing tablets: Montelukastum 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 4
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 5
28 Tablet(s)
16.80
34.70
10 %
Chewing tablets: Montelukastum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 5
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Ropinirol-Mepha retard 2 mg
28 Tablet(s)
16.16
34.00
10 %
Delayed release tablets: Ropinirolum 2 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Ropinirol-Mepha retard 4 mg
28 Tablet(s)
28.72
47.65
10 %
Delayed release tablets: Ropinirolum 4 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Ropinirol-Mepha retard 8 mg
28 Tablet(s)
47.71
68.30
10 %
Delayed release tablets: Ropinirolum 8 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 10
30
18.00
35.95
10 %
Coated tablets: Montelukastum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Montelukast Spirig HC 10
100
59.82
81.40
10 %
Coated tablets: Montelukastum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Celecoxib-Mepha 100 mg
30 Capsule(s)
9.51
26.70
10 %
Capsules: Celecoxibum 100 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Celecoxib-Mepha 200 mg
30 Capsule(s)
14.35
32.00
10 %
Capsules: Celecoxibum 200 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Celecoxib-Mepha 200 mg
100 Capsule(s)
46.27
66.60
10 %
Capsules: Celecoxibum 200 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Telmisartan Zentiva 40 mg
30
15.65
33.35
10 %
Tablets: Telmisartanum 40 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Telmisartan Zentiva 40 mg
100
48.03
68.40
10 %
Tablets: Telmisartanum 40 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Telmisartan Zentiva 80 mg
30
18.82
36.75
10 %
Tablets: Telmisartanum 80 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Telmisartan Zentiva 80 mg
100
62.21
83.80
10 %
Tablets: Telmisartanum 80 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
PP
Constella
28 Capsule(s)
52.28
73.25
10 %
Capsules: Linaclotidum
AbbVie AG
B / SL
FB
G
IP
CI
PP
Constella
90 Capsule(s)
142.84
171.75
10 %
Capsules: Linaclotidum
AbbVie AG
B / SL
FB
G
IP
CI
Gaviscon Mint
8 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Erdbeer
8 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Mint
16 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Erdbeer
16 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Erdbeer
24 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Mint
32 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Erdbeer
32 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Mint
48 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Erdbeer
48 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Mint
64 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Erdbeer
64 Tablet(s)
PR
PR
k.A.
Chewing tablets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
Azzalure
Durchstechflasche(n)
PR
PR
k.A.
Future Health Pharma
GmbH
A
FB
G
IP
Azzalure
2 Durchstechflasche(n)
PR
PR
k.A.
Future Health Pharma
GmbH
A
FB
G
IP
CI
Ropinirol-Mepha retard 2 mg
21 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Ropinirolum 2 mg
Mepha Pharma AG
B
FB
G
IP
CI
Gaviscon Liquid Mint
12 Sachet(s)
PR
PR
k.A.
Suspension zum Einnehmen in Sachets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
CI
Gaviscon Liquid Mint
24 Sachet(s)
PR
PR
k.A.
Suspension zum Einnehmen in Sachets: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
IP
Dorzolamid plus Spirig HC
5 ml
12.90
27.10
k.A.
2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
Dorzolamid plus Spirig HC
3 x 5 ml
37.92
59.95
k.A.
2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
Latanofta
2.5 ml
9.84
19.50
k.A.
Latanoprostum
OPHTAPHARM SA in
Liquidation
B
FB
G
IP
Latanofta
3 x 2.5 ml
28.83
49.50
k.A.
Latanoprostum
OPHTAPHARM SA in
Liquidation
B
FB
G
IP
CI
Desloradix-Mepha 5 mg
10 Tablet(s)
PR
PR
k.A.
Mepha Pharma AG
B
FB
G
IP
CI
Desloradix-Mepha 5 mg
30 Tablet(s)
PR
PR
k.A.
Mepha Pharma AG
B
FB
G
IP
CI
Desloradix-Mepha 5 mg
50 Tablet(s)
PR
PR
k.A.
Mepha Pharma AG
B
FB
G
Nevirapin Sandoz 200 mg
14 Tablet(s)
PR
PR
k.A.
Sandoz
Pharmaceuticals AG
A
FB
G
Nevirapin Sandoz 200 mg
60 Tablet(s)
PR
PR
k.A.
Sandoz
Pharmaceuticals AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home